Blood levels of growth and progression factors in patients with locally advanced breast cancer during neoadjuvant chemotherapy
Purpose of the study. An analysis of blood levels of TGF-β, TGFR2, TNF-α, TNF-αR1, TNF-αR2, CD44 and MMP9 in patients with various biological subtypes of breast cancer receiving neoadjuvant chemotherapy.Materials and methods. This article presents an analysis of levels of growth and progression fact...
Saved in:
Main Authors: | E. M. Frantsiyants, N. Yu. Samaneva, L. Yu. Vladimirova, A. E. Storozhakova, E. A. Kalabanova, S. N. Kabanov, A. V. Tishina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ANO "Perspective of oncology"
2021-09-01
|
Series: | Южно-Российский онкологический журнал |
Subjects: | |
Online Access: | https://www.cancersp.com/jour/article/view/124 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of drug therapy for classical Hodgkin lymphoma
by: N. Y. Samaneva, et al.
Published: (2022-09-01) -
Time course of changes in 6-sulfatoxymelatonin excretion in patients with breast cancer after various neoadjuvant chemotherapy options
by: Yu. S. Sidorenko, et al.
Published: (2014-07-01) -
Surgical treatment of retroperitoneal neuroblastoma in children. Clinical experience
by: S. A. Kuznetsov, et al.
Published: (2022-03-01) -
COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01) -
CLINICAL CASE OF TREATMENT OF INVASIVE UROTHELIAL CANCER OF THE UPPER URINARY TRACT. PROBLEMS OF COMBINED TREATMENT
by: A. A. Klimenko, et al.
Published: (2018-03-01)